Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Lepu Biopharma Co. Ltd. Class H ( (HK:2157) ) is now available.
Lepu Biopharma Co., Ltd. has received approval from the Hong Kong Stock Exchange for the listing of 54,268,364 H shares, marking a significant step in its conversion and listing process. This approval allows the company to convert its unlisted shares, held by four main stakeholders, into H shares, which will now represent approximately 3.17% of the company’s total issued shares. This move is expected to enhance the company’s market presence and provide greater liquidity for its shares.
More about Lepu Biopharma Co. Ltd. Class H
Lepu Biopharma Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating in the biopharmaceutical industry. The company focuses on the development and commercialization of innovative pharmaceuticals and medical devices.
Average Trading Volume: 23,052,072
Technical Sentiment Signal: Buy
Current Market Cap: HK$9.03B
Learn more about 2157 stock on TipRanks’ Stock Analysis page.